Mixed connective tissue disease (MCTD) is a rare connective tissue disorder with clinical features that overlap with systemic lupus erythematous, systemic sclerosis, and polymyositis. We report the case of a patient who presented with dysphagia, 25-lb weight loss, difficulty opening her mouth, and joint pain. Dysphagia workup showed a normal barium swallow and normalappearing EGD but esophageal manometry consistent with severe dysmotility. Through further laboratory and imaging studies, the patient met the diagnostic criteria for MCTD. She had marked improvement in her dysphagia with steroids, biologic therapy, and intravenous immunoglobulin.
Introduction
Mixed connective tissue disease (MCTD) is a rare disorder with an estimated incidence 2.1 per million per year [1] . It is referred to as an "overlap" syndrome, as clinical manifestations can be a mix of symptoms seen in scleroderma, polymyositis, and systemic lupus erythematous. Almost any organ system can be involved, with esophageal symptoms being among the most common presentations (45-80%). Heartburn (48%) and dysphagia (38%) are the most common gastrointestinal symptoms reported in MCTD, but many patients may be asymptomatic [2] . A thorough gastroenterology workup may be warranted to exclude other etiologies of esophageal disorders.
Case Report
A 54-year-old African-American female presented with 3 months of progressive painless dysphagia. She reported "jaw locking" with eating and had an unintentional 25-lb weight loss (baseline weight 160 lbs). The patient complained of new joint pain in her hands, periorbital rash, and alopecia. Physical examination was notable for temporal wasting, inability to open her mouth more than 1 inch, and bilateral sclerodactyly. Initial laboratory studies were significant for a positive ANA (1:1,280). She underwent a barium swallow that showed normal swallow function with no mass, stricture, or evidence of aspiration. EGD showed a normal-appearing esophagus with a single nonobstructing Schatzki ring (Fig. 1 ). Random biopsies of the esophagus were only significant for scattered neutrophils. The patient underwent high-resolution esophageal manometry that showed normal lower esophageal sphincter pressure and normal relaxation after deglutition, but peristalsis was impaired with 80% failed swallows (Fig. 2) . Her esophageal manometry results were consistent with ineffective esophageal motility. The patient was started on high-dose prednisone and intravenous immunoglobulin with improvement in her symptoms. She could be transitioned to low-dose prednisone, mycophenolate mofetil, hydroxychloroquine, and intravenous immunoglobulin for long-term therapy. Her dysphagia improved and she was able to regain her baseline weight. Her CK decreased to 286 IU/L (normal 24-170 IU/L). She underwent repeat esophageal manometry 6 months after starting treatment which showed normal lower esophageal sphincter resting pressure and normal esophageal motility with 70% normal swallows (Fig. 3) .
Discussion
MCTD is frequently associated with esophageal dysmotility, with GERD and dysphagia being the most frequently reported clinical manifestations. Esophageal dysmotility in MCTD can be subclinical at onset, and up to one-third of patients with abnormal manometry tests are asymptomatic [2] [3] [4] [5] . Esophageal manometry has demonstrated that changes in motility are typically due to aperistalsis in the lower two-thirds of the esophagus, but can also involve Repeat high-resolution esophageal manometry after 6 months of therapy showed an intact contraction pattern with mildly impaired relaxation of the lower esophageal sphincter. Esophageal motility was markedly improved with 70% normal swallows.
